Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines

Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targets, therapeutic proteins must cross the plasma membrane. This has previously been achieved by covalent attachment to a variety of cell-penetrating peptides (CPPs). However, there is limited informati...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 9; no. 1; p. 6298
Main Authors Patel, Sanjay G., Sayers, Edward J., He, Lin, Narayan, Rohan, Williams, Thomas L., Mills, Emily M., Allemann, Rudolf K., Luk, Louis Y. P., Jones, Arwyn T., Tsai, Yu-Hsuan
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 18.04.2019
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targets, therapeutic proteins must cross the plasma membrane. This has previously been achieved by covalent attachment to a variety of cell-penetrating peptides (CPPs). However, there is limited information on the relative performance of CPPs in delivering proteins to cells, specifically the cytosol and other intracellular locations. Here we use green fluorescent protein (GFP) as a model cargo to compare delivery capacity of five CPP sequences (Penetratin, R8, TAT, Transportan, Xentry) and cyclic derivatives in different human cell lines (HeLa, HEK, 10T1/2, HepG2) representing different tissues. Confocal microscopy analysis indicates that most fusion proteins when incubated with cells at 10 µM localise to endosomes. Quantification of cellular uptake by flow cytometry reveals that uptake depends on both cell type (10T1/2 > HepG2 > HeLa > HEK), and CPP sequence (Transportan > R8 > Penetratin≈TAT > Xentry). CPP sequence cyclisation or addition of a HA-sequence increased cellular uptake, but fluorescence was still contained in vesicles with no evidence of endosomal escape. Our results provide a guide to select CPP for endosomal/lysosomal delivery and a basis for developing more efficient CPPs in the future.
AbstractList Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targets, therapeutic proteins must cross the plasma membrane. This has previously been achieved by covalent attachment to a variety of cell-penetrating peptides (CPPs). However, there is limited information on the relative performance of CPPs in delivering proteins to cells, specifically the cytosol and other intracellular locations. Here we use green fluorescent protein (GFP) as a model cargo to compare delivery capacity of five CPP sequences (Penetratin, R8, TAT, Transportan, Xentry) and cyclic derivatives in different human cell lines (HeLa, HEK, 10T1/2, HepG2) representing different tissues. Confocal microscopy analysis indicates that most fusion proteins when incubated with cells at 10 µM localise to endosomes. Quantification of cellular uptake by flow cytometry reveals that uptake depends on both cell type (10T1/2 > HepG2 > HeLa > HEK), and CPP sequence (Transportan > R8 > Penetratin≈TAT > Xentry). CPP sequence cyclisation or addition of a HA-sequence increased cellular uptake, but fluorescence was still contained in vesicles with no evidence of endosomal escape. Our results provide a guide to select CPP for endosomal/lysosomal delivery and a basis for developing more efficient CPPs in the future.
Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targets, therapeutic proteins must cross the plasma membrane. This has previously been achieved by covalent attachment to a variety of cell-penetrating peptides (CPPs). However, there is limited information on the relative performance of CPPs in delivering proteins to cells, specifically the cytosol and other intracellular locations. Here we use green fluorescent protein (GFP) as a model cargo to compare delivery capacity of five CPP sequences (Penetratin, R8, TAT, Transportan, Xentry) and cyclic derivatives in different human cell lines (HeLa, HEK, 10T1/2, HepG2) representing different tissues. Confocal microscopy analysis indicates that most fusion proteins when incubated with cells at 10 µM localise to endosomes. Quantification of cellular uptake by flow cytometry reveals that uptake depends on both cell type (10T1/2 > HepG2 > HeLa > HEK), and CPP sequence (Transportan > R8 > Penetratin≈TAT > Xentry). CPP sequence cyclisation or addition of a HA-sequence increased cellular uptake, but fluorescence was still contained in vesicles with no evidence of endosomal escape. Our results provide a guide to select CPP for endosomal/lysosomal delivery and a basis for developing more efficient CPPs in the future.Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targets, therapeutic proteins must cross the plasma membrane. This has previously been achieved by covalent attachment to a variety of cell-penetrating peptides (CPPs). However, there is limited information on the relative performance of CPPs in delivering proteins to cells, specifically the cytosol and other intracellular locations. Here we use green fluorescent protein (GFP) as a model cargo to compare delivery capacity of five CPP sequences (Penetratin, R8, TAT, Transportan, Xentry) and cyclic derivatives in different human cell lines (HeLa, HEK, 10T1/2, HepG2) representing different tissues. Confocal microscopy analysis indicates that most fusion proteins when incubated with cells at 10 µM localise to endosomes. Quantification of cellular uptake by flow cytometry reveals that uptake depends on both cell type (10T1/2 > HepG2 > HeLa > HEK), and CPP sequence (Transportan > R8 > Penetratin≈TAT > Xentry). CPP sequence cyclisation or addition of a HA-sequence increased cellular uptake, but fluorescence was still contained in vesicles with no evidence of endosomal escape. Our results provide a guide to select CPP for endosomal/lysosomal delivery and a basis for developing more efficient CPPs in the future.
ArticleNumber 6298
Author Patel, Sanjay G.
Williams, Thomas L.
Sayers, Edward J.
He, Lin
Tsai, Yu-Hsuan
Narayan, Rohan
Allemann, Rudolf K.
Jones, Arwyn T.
Mills, Emily M.
Luk, Louis Y. P.
Author_xml – sequence: 1
  givenname: Sanjay G.
  surname: Patel
  fullname: Patel, Sanjay G.
  organization: School of Chemistry, Cardiff University
– sequence: 2
  givenname: Edward J.
  orcidid: 0000-0002-2621-1119
  surname: Sayers
  fullname: Sayers, Edward J.
  organization: School of Pharmacy and Pharmaceutical Sciences, Cardiff University
– sequence: 3
  givenname: Lin
  surname: He
  fullname: He, Lin
  organization: School of Pharmacy and Pharmaceutical Sciences, Cardiff University
– sequence: 4
  givenname: Rohan
  surname: Narayan
  fullname: Narayan, Rohan
  organization: School of Pharmacy and Pharmaceutical Sciences, Cardiff University
– sequence: 5
  givenname: Thomas L.
  surname: Williams
  fullname: Williams, Thomas L.
  organization: School of Chemistry, Cardiff University
– sequence: 6
  givenname: Emily M.
  surname: Mills
  fullname: Mills, Emily M.
  organization: School of Chemistry, Cardiff University
– sequence: 7
  givenname: Rudolf K.
  surname: Allemann
  fullname: Allemann, Rudolf K.
  organization: School of Chemistry, Cardiff University
– sequence: 8
  givenname: Louis Y. P.
  surname: Luk
  fullname: Luk, Louis Y. P.
  organization: School of Chemistry, Cardiff University
– sequence: 9
  givenname: Arwyn T.
  orcidid: 0000-0003-2781-8905
  surname: Jones
  fullname: Jones, Arwyn T.
  email: jonesat@cardiff.ac.uk
  organization: School of Pharmacy and Pharmaceutical Sciences, Cardiff University
– sequence: 10
  givenname: Yu-Hsuan
  orcidid: 0000-0003-0589-5088
  surname: Tsai
  fullname: Tsai, Yu-Hsuan
  email: tsaiy5@cardiff.ac.uk
  organization: School of Chemistry, Cardiff University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31000738$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1vFSEUhiemxtbaP-DCkLhxM8rnHdiYmBu_kiZudE0YOFypc2EEpon_wx8sc2-ttYsSEr6e9-UcOE-7k5gidN1zgl8TzOSbwolQssdE9Zxysenlo-6MYi56yig9uTM_7S5KucKtCao4UU-6U0baamDyrPu9hWnqZ4hQs6kh7tAMcw0OUIGfC0QLyESH9skFH2wjUkQOGu8gVrTM1fw4EmUZbbNaJpORC6XmMC4HOnm0ywAR-SllKHbVzTlVCBG13nw95HVzlaMpRCjPusfeTAUubsbz7tuH91-3n_rLLx8_b99d9lYMQ-0JCGalV9g7RSVxTnoj2MixFco4QikIw51kno4YSyAj3ygvuR8VHwcuLDvv3h5952Xcg1tDy2bScw57k3_pZIL-_ySG73qXrvWGD5Rx2gxe3Rjk1F6rVL0PZc3DREhL0ZQSojhnTDT05T30Ki05tvQOFGNYDZtGvbgb0W0ofz-sAfQI2JxKyeBvEYL1Whj6WBi6FYY-FIZeRfKeyIZ6-MuWVZgelrKjtLR74g7yv7AfUP0B59PQ3w
CitedBy_id crossref_primary_10_1016_j_ijbiomac_2023_126520
crossref_primary_10_1016_j_peptides_2021_170542
crossref_primary_10_3390_pharmaceutics13060878
crossref_primary_10_1016_j_bbrep_2024_101745
crossref_primary_10_1039_D1DT00060H
crossref_primary_10_1038_s42003_022_04110_4
crossref_primary_10_1016_j_drudis_2024_104070
crossref_primary_10_2967_jnumed_120_251173
crossref_primary_10_1186_s12943_023_01807_w
crossref_primary_10_2174_1570162X17666191121114522
crossref_primary_10_1038_s41598_023_37280_0
crossref_primary_10_1021_acs_molpharmaceut_2c00783
crossref_primary_10_3390_ijms252212138
crossref_primary_10_1002_wnan_1668
crossref_primary_10_3390_toxins13020147
crossref_primary_10_3390_toxins13020146
crossref_primary_10_3389_fphar_2022_1056467
crossref_primary_10_1016_j_lfs_2024_122526
crossref_primary_10_1371_journal_pone_0296727
crossref_primary_10_1021_acs_bioconjchem_1c00103
crossref_primary_10_3390_ijms21124251
crossref_primary_10_1039_D1CB00024A
crossref_primary_10_3389_fphar_2021_658805
crossref_primary_10_3390_cells11142141
crossref_primary_10_3390_ijms22169092
crossref_primary_10_1016_j_archoralbio_2021_105215
crossref_primary_10_2147_IJN_S370478
crossref_primary_10_1016_j_abb_2021_108751
crossref_primary_10_1039_D1NH00254F
crossref_primary_10_3390_molecules29174088
crossref_primary_10_1080_1061186X_2019_1669041
crossref_primary_10_1021_acsomega_3c09689
crossref_primary_10_3390_ma12172671
crossref_primary_10_1016_j_addr_2021_02_003
crossref_primary_10_1038_s41467_024_48221_4
crossref_primary_10_1002_btpr_3014
crossref_primary_10_1002_mabi_202300312
crossref_primary_10_1038_s41598_024_56663_5
crossref_primary_10_1111_bcp_14611
crossref_primary_10_1111_jfb_15154
crossref_primary_10_1186_s12951_022_01309_9
crossref_primary_10_1039_D2MD00097K
crossref_primary_10_1039_D4CS00483C
crossref_primary_10_3390_v13102043
crossref_primary_10_1021_acs_orglett_3c02112
crossref_primary_10_1089_bioe_2020_0012
crossref_primary_10_1039_D1BM00819F
crossref_primary_10_3390_cells11233834
crossref_primary_10_3390_ijms26062649
crossref_primary_10_1016_j_addr_2020_08_008
crossref_primary_10_1021_acsabm_0c01563
crossref_primary_10_1172_JCI156211
crossref_primary_10_1002_pep2_24163
crossref_primary_10_1021_acs_langmuir_2c00269
crossref_primary_10_1016_j_jconrel_2020_12_020
crossref_primary_10_1002_jev2_12462
crossref_primary_10_1007_s10989_023_10524_3
crossref_primary_10_1016_j_chembiol_2024_09_003
crossref_primary_10_3390_cells11071195
crossref_primary_10_1002_adhm_202102118
crossref_primary_10_1007_s12033_021_00433_5
crossref_primary_10_1021_acsbiomaterials_2c00476
crossref_primary_10_1016_j_jddst_2022_103362
crossref_primary_10_3390_biom12121844
crossref_primary_10_1038_s41420_024_02070_8
crossref_primary_10_1039_D1CB00154J
crossref_primary_10_1042_BCJ20190452
crossref_primary_10_1002_psc_3359
crossref_primary_10_1021_polymscitech_4c00026
crossref_primary_10_3390_pharmaceutics16010073
crossref_primary_10_1002_cbic_202401040
crossref_primary_10_1021_acsnano_0c09115
crossref_primary_10_3390_pharmaceutics16111443
crossref_primary_10_1371_journal_pbio_3002522
crossref_primary_10_1002_jms_4681
crossref_primary_10_3390_membranes12060600
crossref_primary_10_7554_eLife_60360
crossref_primary_10_1007_s10529_020_02909_x
crossref_primary_10_1021_acs_biomac_4c01342
crossref_primary_10_1007_s40259_020_00419_w
crossref_primary_10_1016_j_jconrel_2023_09_022
crossref_primary_10_1089_hum_2024_020
crossref_primary_10_1002_smll_202006000
crossref_primary_10_3390_membranes12020180
crossref_primary_10_3390_molecules24234318
crossref_primary_10_1038_s41467_025_56204_2
crossref_primary_10_1002_pep2_24224
crossref_primary_10_1016_j_ebiom_2021_103610
crossref_primary_10_1038_s41467_020_20577_3
crossref_primary_10_1021_acs_analchem_0c03762
crossref_primary_10_1007_s00232_020_00109_2
crossref_primary_10_1002_wnan_1853
crossref_primary_10_1016_j_tips_2020_08_005
crossref_primary_10_1016_j_critrevonc_2023_104088
crossref_primary_10_1021_acs_molpharmaceut_3c00444
crossref_primary_10_1016_j_bbamem_2021_183820
crossref_primary_10_1002_elps_202200067
crossref_primary_10_4014_jmb_2207_07058
crossref_primary_10_3390_antibiotics12071216
crossref_primary_10_3390_ph15050540
crossref_primary_10_1016_j_biosx_2022_100259
crossref_primary_10_1186_s12951_022_01514_6
crossref_primary_10_31083_j_fbl2702064
crossref_primary_10_1021_jacsau_2c00654
crossref_primary_10_3390_ijms21020442
crossref_primary_10_1039_C9CC07931A
crossref_primary_10_1016_j_isci_2024_111029
crossref_primary_10_1371_journal_pone_0305848
crossref_primary_10_1002_psc_3298
crossref_primary_10_1021_acs_jmedchem_3c00628
crossref_primary_10_1007_s12274_023_6026_y
crossref_primary_10_1007_s13205_024_03958_z
crossref_primary_10_1021_acsomega_9b01353
crossref_primary_10_3390_pharmaceutics15082093
crossref_primary_10_1021_acschembio_4c00211
crossref_primary_10_1002_chem_202005000
crossref_primary_10_1002_cbic_202200115
crossref_primary_10_1007_s13770_023_00572_7
crossref_primary_10_1021_acs_biochem_4c00418
crossref_primary_10_3390_biom14091073
crossref_primary_10_1080_17425247_2019_1665021
crossref_primary_10_1371_journal_pone_0310083
crossref_primary_10_1016_j_biomaterials_2020_120461
crossref_primary_10_1038_s42004_023_00890_w
crossref_primary_10_3389_fphar_2022_1049324
crossref_primary_10_1021_acsabm_0c00421
crossref_primary_10_1016_j_jconrel_2022_09_040
crossref_primary_10_1007_s10616_023_00591_1
crossref_primary_10_1021_acssynbio_3c00670
crossref_primary_10_3892_etm_2019_8368
crossref_primary_10_3390_ph15101283
crossref_primary_10_1002_mame_202400007
crossref_primary_10_1016_j_ejps_2021_105790
crossref_primary_10_1111_sji_12875
crossref_primary_10_1002_smll_202303138
crossref_primary_10_3390_pharmaceutics15041267
crossref_primary_10_3389_fcimb_2022_838259
crossref_primary_10_3390_biom10020217
crossref_primary_10_1021_acschembio_0c00593
crossref_primary_10_1039_D1OB00411E
crossref_primary_10_1002_iub_2826
crossref_primary_10_1021_acsanm_3c05423
crossref_primary_10_1111_joa_13365
crossref_primary_10_1016_j_ymthe_2021_06_009
crossref_primary_10_1021_acs_molpharmaceut_1c00924
crossref_primary_10_1021_acsomega_1c00532
crossref_primary_10_1038_s41598_024_55274_4
crossref_primary_10_3390_antib12010024
crossref_primary_10_1038_s41598_021_87134_w
crossref_primary_10_3390_pharmaceutics16091199
crossref_primary_10_3390_ph18030297
crossref_primary_10_3390_pharmaceutics15061610
crossref_primary_10_1093_nar_gkae471
crossref_primary_10_1128_msystems_00646_23
crossref_primary_10_1016_j_addr_2021_114087
crossref_primary_10_1016_j_bbapap_2021_140604
crossref_primary_10_3390_pharmaceutics13070987
crossref_primary_10_1021_acs_chemmater_2c01736
crossref_primary_10_1186_s12987_024_00545_5
crossref_primary_10_1016_j_bioorg_2023_106892
crossref_primary_10_1080_1061186X_2021_1906885
crossref_primary_10_1002_btpr_3071
crossref_primary_10_1016_j_heliyon_2023_e15945
crossref_primary_10_1080_15257770_2023_2228841
crossref_primary_10_1016_j_mtbio_2022_100248
crossref_primary_10_1038_s41598_021_01331_1
crossref_primary_10_1002_adma_202008517
crossref_primary_10_1002_prot_26604
crossref_primary_10_1038_s41557_021_00661_x
crossref_primary_10_1016_j_bmcl_2024_129682
crossref_primary_10_1080_1061186X_2021_1941059
crossref_primary_10_3390_pharmaceutics14081699
crossref_primary_10_1002_aic_17087
crossref_primary_10_1152_ajpcell_00435_2020
crossref_primary_10_1016_j_antiviral_2020_104971
crossref_primary_10_1016_j_engreg_2022_02_004
crossref_primary_10_1002_cbic_202400450
crossref_primary_10_1016_j_biopha_2024_116910
crossref_primary_10_1039_D4CB00199K
crossref_primary_10_2174_2210681213666230504115152
crossref_primary_10_1016_j_bcp_2024_116478
crossref_primary_10_1002_advs_202416963
crossref_primary_10_1002_ddr_22076
crossref_primary_10_1016_j_saa_2020_119410
crossref_primary_10_1021_acsabm_3c00659
crossref_primary_10_3390_ph16030469
crossref_primary_10_1042_BCJ20200006
crossref_primary_10_1080_1061186X_2020_1870230
crossref_primary_10_1002_jev2_12044
crossref_primary_10_1016_j_biomaterials_2024_122856
crossref_primary_10_3390_ijms23010265
Cites_doi 10.1016/j.biomaterials.2012.02.049
10.1038/srep04900
10.1016/j.bbamem.2005.04.010
10.1038/nrd1178
10.1039/c2cc31887c
10.1371/journal.pone.0047132
10.1016/j.febslet.2013.04.031
10.1101/cshperspect.a016931
10.1038/nrd2399
10.1038/srep01661
10.1016/j.bbamem.2007.03.029
10.1126/science.3018930
10.1016/j.jconrel.2013.11.020
10.1042/BJ20070507
10.1517/17425247.2016.1125879
10.1002/psc.968
10.1016/0092-8674(89)90417-0
10.1038/nchem.2811
10.1016/j.jconrel.2012.04.003
10.1042/BJ20061100
10.1016/j.bbagen.2011.05.013
10.1021/bc800194e
10.1038/nm996
10.1007/s00249-011-0682-7
10.1002/anie.201410006
10.3390/ph5111177
10.1038/ncomms1459
10.1074/jbc.271.30.18188
10.1073/pnas.95.12.6803
10.1002/jbm.b.33354
10.1038/s41598-018-25600-8
10.1038/nchem.2224
ContentType Journal Article
Copyright The Author(s) 2019
The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2019
– notice: The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/s41598-019-42456-8
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (via ProQuest)
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database (via ProQuest SciTech Premium Collection)
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID PMC6472342
31000738
10_1038_s41598_019_42456_8
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
  grantid: BB/P009980/1; BB/P009980/1; BB/P009980/1; BB/P009980/1
  funderid: https://doi.org/10.13039/501100000268
– fundername: RCUK | Engineering and Physical Sciences Research Council (EPSRC)
  grantid: EP/P511122/1; EP/P511122/1
  funderid: https://doi.org/10.13039/501100000266
– fundername: Cancer Research UK (CRUK)
  funderid: https://doi.org/10.13039/501100000289
– fundername: Wellcome Trust (Wellcome)
  grantid: 202056/Z/16/Z
  funderid: https://doi.org/10.13039/100004440
– fundername: Biotechnology and Biological Sciences Research Council
  grantid: BB/D013038/1
– fundername: Wellcome Trust
– fundername: Cancer Research UK
– fundername: Wellcome Trust
  grantid: 202056/Z/16/Z
– fundername: Wellcome Trust
  grantid: 200730/Z/16/Z
– fundername: Biotechnology and Biological Sciences Research Council
  grantid: BB/P009980/1
– fundername: ;
– fundername: ;
  grantid: 202056/Z/16/Z
– fundername: ;
  grantid: EP/P511122/1; EP/P511122/1
– fundername: ;
  grantid: BB/P009980/1; BB/P009980/1; BB/P009980/1; BB/P009980/1
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c577t-1e53c8f90fd9281dd8fa53b40c59ad122e5a4d83f2b008e1b469f84fb94b745c3
IEDL.DBID M48
ISSN 2045-2322
IngestDate Thu Aug 21 14:14:02 EDT 2025
Fri Jul 11 08:39:01 EDT 2025
Wed Aug 13 06:43:45 EDT 2025
Mon Jul 21 06:02:43 EDT 2025
Tue Jul 01 03:08:40 EDT 2025
Thu Apr 24 23:07:59 EDT 2025
Fri Feb 21 02:38:43 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c577t-1e53c8f90fd9281dd8fa53b40c59ad122e5a4d83f2b008e1b469f84fb94b745c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2781-8905
0000-0003-0589-5088
0000-0002-2621-1119
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-019-42456-8
PMID 31000738
PQID 2211330976
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6472342
proquest_miscellaneous_2211944335
proquest_journals_2211330976
pubmed_primary_31000738
crossref_primary_10_1038_s41598_019_42456_8
crossref_citationtrail_10_1038_s41598_019_42456_8
springer_journals_10_1038_s41598_019_42456_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-04-18
PublicationDateYYYYMMDD 2019-04-18
PublicationDate_xml – month: 04
  year: 2019
  text: 2019-04-18
  day: 18
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2019
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Montrose (CR23) 2013; 3
Maxfield (CR32) 2014; 6
Arpino, Rizkallah, Jones (CR27) 2012; 7
Green, Ishino, Loewenstein (CR11) 1989; 58
Wang (CR6) 2014; 174
El-Andaloussi, Jarver, Johansson, Langel (CR13) 2007; 407
Wadia, Stan, Dowdy (CR20) 2004; 10
Splith, Neundorf (CR24) 2011; 40
Llopis (CR31) 1998; 95
Nischan (CR9) 2015; 54
Reddington, Tippmann, Jones (CR17) 2012; 48
Lattig-Tunnemann (CR19) 2011; 2
Tunnemann (CR15) 2008; 14
Lee, Johnson, Peltier, Pellois (CR28) 2011; 1810
Kurrikoff, Gestin, Langel (CR5) 2016; 13
Derossi (CR22) 1996; 271
Jones, Sayers (CR4) 2012; 161
Fang, Chen, Godbey (CR2) 2015; 103
Herce (CR10) 2017; 9
Reichert (CR3) 2003; 2
Maiolo, Ferrer, Ottinger (CR12) 2005; 1712
Bachmair, Finley, Varshavsky (CR26) 1986; 234
Leader, Baca, Golan (CR1) 2008; 7
Bechara, Sagan (CR7) 2013; 587
David, Vila-Perello, Verma, Muir (CR21) 2015; 7
Henriques, Melo, Castanho (CR25) 2006; 399
Montrose, Yang, Krissansen (CR29) 2014; 4
Hitsuda (CR16) 2012; 33
Mueller, Kretzschmar, Volkmer, Boisguerin (CR14) 2008; 19
Palm, Jayamanne, Kjellander, Hallbrink (CR30) 2007; 1768
Erazo-Oliveras (CR8) 2012; 5
He, Sayers, Watson, Jones (CR18) 2018; 8
JS Wadia (42456_CR20) 2004; 10
K Montrose (42456_CR23) 2013; 3
K Splith (42456_CR24) 2011; 40
F Wang (42456_CR6) 2014; 174
Y David (42456_CR21) 2015; 7
T Hitsuda (42456_CR16) 2012; 33
D Derossi (42456_CR22) 1996; 271
A Bachmair (42456_CR26) 1986; 234
AT Jones (42456_CR4) 2012; 161
JM Reichert (42456_CR3) 2003; 2
C Bechara (42456_CR7) 2013; 587
M Green (42456_CR11) 1989; 58
YL Fang (42456_CR2) 2015; 103
L He (42456_CR18) 2018; 8
JAJ Arpino (42456_CR27) 2012; 7
C Palm (42456_CR30) 2007; 1768
A Erazo-Oliveras (42456_CR8) 2012; 5
S El-Andaloussi (42456_CR13) 2007; 407
N Nischan (42456_CR9) 2015; 54
ST Henriques (42456_CR25) 2006; 399
K Montrose (42456_CR29) 2014; 4
SC Reddington (42456_CR17) 2012; 48
YJ Lee (42456_CR28) 2011; 1810
K Kurrikoff (42456_CR5) 2016; 13
JR Maiolo (42456_CR12) 2005; 1712
HD Herce (42456_CR10) 2017; 9
G Tunnemann (42456_CR15) 2008; 14
G Lattig-Tunnemann (42456_CR19) 2011; 2
J Mueller (42456_CR14) 2008; 19
B Leader (42456_CR1) 2008; 7
FR Maxfield (42456_CR32) 2014; 6
J Llopis (42456_CR31) 1998; 95
References_xml – volume: 33
  start-page: 4665
  year: 2012
  end-page: 4672
  ident: CR16
  article-title: A protein transduction method using oligo-arginine (3R) for the delivery of transcription factors into cell nuclei
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2012.02.049
– volume: 4
  year: 2014
  ident: CR29
  article-title: The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry
  publication-title: Sci. Rep.
  doi: 10.1038/srep04900
– volume: 1712
  start-page: 161
  year: 2005
  end-page: 172
  ident: CR12
  article-title: Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamem.2005.04.010
– volume: 2
  start-page: 695
  year: 2003
  end-page: 702
  ident: CR3
  article-title: Trends in development and approval times for new therapeutics in the United States
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd1178
– volume: 48
  start-page: 8419
  year: 2012
  end-page: 8421
  ident: CR17
  article-title: Residue choice defines efficiency and influence of bioorthogonal protein modification via genetically encoded strain promoted Click chemistry
  publication-title: Chem. Commun.
  doi: 10.1039/c2cc31887c
– volume: 7
  start-page: e47132
  year: 2012
  ident: CR27
  article-title: Crystal Structure of Enhanced Green Fluorescent Protein to 1.35 angstrom Resolution Reveals Alternative Conformations for Glu222
  publication-title: Plos One
  doi: 10.1371/journal.pone.0047132
– volume: 587
  start-page: 1693
  year: 2013
  end-page: 1702
  ident: CR7
  article-title: Cell-penetrating peptides: 20 years later, where do we stand?
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2013.04.031
– volume: 6
  start-page: a016931
  year: 2014
  ident: CR32
  article-title: Role of Endosomes and Lysosomes in Human Disease
  publication-title: Cold Spring Harb. Perspect Biol.
  doi: 10.1101/cshperspect.a016931
– volume: 7
  start-page: 21
  year: 2008
  end-page: 39
  ident: CR1
  article-title: Protein therapeutics: a summary and pharmacological classification
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2399
– volume: 3
  year: 2013
  ident: CR23
  article-title: Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs
  publication-title: Sci. Rep.
  doi: 10.1038/srep01661
– volume: 1768
  start-page: 1769
  year: 2007
  end-page: 1776
  ident: CR30
  article-title: Peptide degradation is a critical determinant for cell-penetrating peptide uptake
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamem.2007.03.029
– volume: 234
  start-page: 179
  year: 1986
  end-page: 186
  ident: CR26
  article-title: Invivo Half-Life of a Protein Is a Function of Its Amino-Terminal Residue
  publication-title: Science
  doi: 10.1126/science.3018930
– volume: 174
  start-page: 126
  year: 2014
  end-page: 136
  ident: CR6
  article-title: Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2013.11.020
– volume: 407
  start-page: 285
  year: 2007
  end-page: 292
  ident: CR13
  article-title: Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study
  publication-title: Biochem. J.
  doi: 10.1042/BJ20070507
– volume: 13
  start-page: 373
  year: 2016
  end-page: 387
  ident: CR5
  article-title: Recent advances in cell-penetrating peptide-assisted drug delivery
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425247.2016.1125879
– volume: 14
  start-page: 469
  year: 2008
  end-page: 476
  ident: CR15
  article-title: Live-cell analysis of cell penetration ability and toxicity of oligo-arginines
  publication-title: J. Pept. Sci.
  doi: 10.1002/psc.968
– volume: 58
  start-page: 215
  year: 1989
  end-page: 223
  ident: CR11
  article-title: Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression
  publication-title: Cell
  doi: 10.1016/0092-8674(89)90417-0
– volume: 9
  start-page: 762
  year: 2017
  end-page: 771
  ident: CR10
  article-title: Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells
  publication-title: Nat. Chem.
  doi: 10.1038/nchem.2811
– volume: 161
  start-page: 582
  year: 2012
  end-page: 591
  ident: CR4
  article-title: Cell entry of cell penetrating peptides: tales of tails wagging dogs
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2012.04.003
– volume: 399
  start-page: 1
  year: 2006
  end-page: 7
  ident: CR25
  article-title: Cell-penetrating peptides and antimicrobial peptides: how different are they?
  publication-title: Biochem. J.
  doi: 10.1042/BJ20061100
– volume: 1810
  start-page: 752
  year: 2011
  end-page: 758
  ident: CR28
  article-title: A HA2-Fusion tag limits the endosomal release of its protein cargo despite causing endosomal lysis
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagen.2011.05.013
– volume: 19
  start-page: 2363
  year: 2008
  end-page: 2374
  ident: CR14
  article-title: Comparison of cellular uptake using 22 CPPs in 4 different cell lines
  publication-title: Bioconjugate Chem.
  doi: 10.1021/bc800194e
– volume: 10
  start-page: 310
  year: 2004
  end-page: 315
  ident: CR20
  article-title: Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis
  publication-title: Nat. Med.
  doi: 10.1038/nm996
– volume: 40
  start-page: 387
  year: 2011
  end-page: 397
  ident: CR24
  article-title: Antimicrobial peptides with cell-penetrating peptide properties and vice versa
  publication-title: Eur. Biophys. J.
  doi: 10.1007/s00249-011-0682-7
– volume: 54
  start-page: 1950
  year: 2015
  end-page: 1953
  ident: CR9
  article-title: Covalent Attachment of Cyclic TAT Peptides to GFP Results in Protein Delivery into Live Cells with Immediate Bioavailability
  publication-title: Angew. Chem. Int. Ed.
  doi: 10.1002/anie.201410006
– volume: 5
  start-page: 1177
  year: 2012
  end-page: 1209
  ident: CR8
  article-title: Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges
  publication-title: Pharmaceuticals
  doi: 10.3390/ph5111177
– volume: 2
  year: 2011
  ident: CR19
  article-title: Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms1459
– volume: 271
  start-page: 18188
  year: 1996
  end-page: 18193
  ident: CR22
  article-title: Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.271.30.18188
– volume: 95
  start-page: 6803
  year: 1998
  end-page: 6808
  ident: CR31
  article-title: Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.95.12.6803
– volume: 103
  start-page: 1679
  year: 2015
  end-page: 1699
  ident: CR2
  article-title: Gene delivery in tissue engineering and regenerative medicine
  publication-title: J Biomed Mater Res B
  doi: 10.1002/jbm.b.33354
– volume: 8
  year: 2018
  ident: CR18
  article-title: Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-25600-8
– volume: 7
  start-page: 394
  year: 2015
  end-page: 402
  ident: CR21
  article-title: Chemical tagging and customizing of cellular chromatin states using ultrafast trans-splicing inteins
  publication-title: Nat. Chem.
  doi: 10.1038/nchem.2224
– volume: 2
  year: 2011
  ident: 42456_CR19
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms1459
– volume: 40
  start-page: 387
  year: 2011
  ident: 42456_CR24
  publication-title: Eur. Biophys. J.
  doi: 10.1007/s00249-011-0682-7
– volume: 234
  start-page: 179
  year: 1986
  ident: 42456_CR26
  publication-title: Science
  doi: 10.1126/science.3018930
– volume: 48
  start-page: 8419
  year: 2012
  ident: 42456_CR17
  publication-title: Chem. Commun.
  doi: 10.1039/c2cc31887c
– volume: 8
  year: 2018
  ident: 42456_CR18
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-25600-8
– volume: 54
  start-page: 1950
  year: 2015
  ident: 42456_CR9
  publication-title: Angew. Chem. Int. Ed.
  doi: 10.1002/anie.201410006
– volume: 1712
  start-page: 161
  year: 2005
  ident: 42456_CR12
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamem.2005.04.010
– volume: 2
  start-page: 695
  year: 2003
  ident: 42456_CR3
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd1178
– volume: 161
  start-page: 582
  year: 2012
  ident: 42456_CR4
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2012.04.003
– volume: 19
  start-page: 2363
  year: 2008
  ident: 42456_CR14
  publication-title: Bioconjugate Chem.
  doi: 10.1021/bc800194e
– volume: 33
  start-page: 4665
  year: 2012
  ident: 42456_CR16
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2012.02.049
– volume: 3
  year: 2013
  ident: 42456_CR23
  publication-title: Sci. Rep.
  doi: 10.1038/srep01661
– volume: 9
  start-page: 762
  year: 2017
  ident: 42456_CR10
  publication-title: Nat. Chem.
  doi: 10.1038/nchem.2811
– volume: 10
  start-page: 310
  year: 2004
  ident: 42456_CR20
  publication-title: Nat. Med.
  doi: 10.1038/nm996
– volume: 95
  start-page: 6803
  year: 1998
  ident: 42456_CR31
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.95.12.6803
– volume: 103
  start-page: 1679
  year: 2015
  ident: 42456_CR2
  publication-title: J Biomed Mater Res B
  doi: 10.1002/jbm.b.33354
– volume: 14
  start-page: 469
  year: 2008
  ident: 42456_CR15
  publication-title: J. Pept. Sci.
  doi: 10.1002/psc.968
– volume: 1768
  start-page: 1769
  year: 2007
  ident: 42456_CR30
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamem.2007.03.029
– volume: 587
  start-page: 1693
  year: 2013
  ident: 42456_CR7
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2013.04.031
– volume: 7
  start-page: 394
  year: 2015
  ident: 42456_CR21
  publication-title: Nat. Chem.
  doi: 10.1038/nchem.2224
– volume: 13
  start-page: 373
  year: 2016
  ident: 42456_CR5
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425247.2016.1125879
– volume: 174
  start-page: 126
  year: 2014
  ident: 42456_CR6
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2013.11.020
– volume: 1810
  start-page: 752
  year: 2011
  ident: 42456_CR28
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagen.2011.05.013
– volume: 7
  start-page: 21
  year: 2008
  ident: 42456_CR1
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2399
– volume: 271
  start-page: 18188
  year: 1996
  ident: 42456_CR22
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.271.30.18188
– volume: 58
  start-page: 215
  year: 1989
  ident: 42456_CR11
  publication-title: Cell
  doi: 10.1016/0092-8674(89)90417-0
– volume: 6
  start-page: a016931
  year: 2014
  ident: 42456_CR32
  publication-title: Cold Spring Harb. Perspect Biol.
  doi: 10.1101/cshperspect.a016931
– volume: 5
  start-page: 1177
  year: 2012
  ident: 42456_CR8
  publication-title: Pharmaceuticals
  doi: 10.3390/ph5111177
– volume: 399
  start-page: 1
  year: 2006
  ident: 42456_CR25
  publication-title: Biochem. J.
  doi: 10.1042/BJ20061100
– volume: 4
  year: 2014
  ident: 42456_CR29
  publication-title: Sci. Rep.
  doi: 10.1038/srep04900
– volume: 7
  start-page: e47132
  year: 2012
  ident: 42456_CR27
  publication-title: Plos One
  doi: 10.1371/journal.pone.0047132
– volume: 407
  start-page: 285
  year: 2007
  ident: 42456_CR13
  publication-title: Biochem. J.
  doi: 10.1042/BJ20070507
SSID ssj0000529419
Score 2.6268995
Snippet Protein therapy holds great promise for treating a variety of diseases. To act on intracellular targets, therapeutic proteins must cross the plasma membrane....
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6298
SubjectTerms 13/31
14/19
631/61/2297
639/638/92/96
82
82/80
82/83
Biological Transport - genetics
Cell lines
Cell Membrane Permeability - drug effects
Cell Membrane Permeability - genetics
Cell-Penetrating Peptides - genetics
Cell-Penetrating Peptides - pharmacology
Confocal microscopy
Cytosol
Cytosol - metabolism
Endocytosis - genetics
Endosomes
Flow cytometry
Fluorescence
Green fluorescent protein
Green Fluorescent Proteins - genetics
Green Fluorescent Proteins - pharmacology
HeLa Cells
Hep G2 Cells
Humanities and Social Sciences
Humans
Intracellular
Lysosomes - genetics
Microscopy, Confocal
multidisciplinary
Peptides
Proteins
Science
Science (multidisciplinary)
SummonAdditionalLinks – databaseName: ProQuest Health & Medical Collection (NC LIVE)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICNxA6sbP9b2CaGKquLAiUp7i-JXqViSQLKH_o_-YGacR7VUVMrNdhJ7xp6nvyHkvXE82CgCc5YrJhMYKC6UigUQNsBQwq98TpD9tj49k183ajM53PoprXI-E_NBHVqPPvIjDpYK2N4gPT91vxlWjcLo6lRC4y65h9BlyNV6oxcfC0axZGmnuzIrYY56kFd4p6y0LIf8mNmXRzeUzJu5kv8ETLMcOnlEHk4KJP08UvwxuRObJ-T-WFLy8im5Oo7bLevgBMt4uM057TBvJUQ6J03Tugn0VxswRyiThc6FcAe664b659ij3zl06mOWKg2IrjsVxqJtoueYrEMTmPojGBTNaA8XDYVnrrgyUBxOUYvtn5Gzky_fj0_ZVHmBeaX1wMqohDfJrlKwHDTaYFKthJMrr2wdSs6jqmUwInHYtSaWDozsZGRyVjotlRfPyUHTNvEloXoNGpDTKQWdpKiTSSYaWwbt12tgFF-Qcl7_yk-w5FgdY1vl8Lgw1UizCmhWZZpVpiAfljHdCMpxa-_DmazVtEH76pqdCvJuaYathWtTN7HdjX2slEKogrwYuWD5XI6LaAEv13v8sXRA2O79lubiR4bvRsB-IXlBPs6cdP1b_5_Fq9tn8Zo84MjViEJpDsnB8GcX34C6NLi3eU_8Ba02Fm8
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwEB5RUKVeENBXWqhcqTewmvixsY8rVIT20AtF4hbFL4q6za662QP_gx_M2HmgLS0SUm4eJ45nbI89n78B-KIMc9pzR41mkoqAGxTjCkkdLjZoUNzmNgFkv0_OL8XsSl5tARvuwiTQfqK0TNP0gA77usKFJl4GKzRNsTqqXsBOpGpH296ZTmcXs_FkJcauRKH7GzI5V_-ovLkKPXItHyMk_wqTptXnbA92e7eRTLuG7sOWbw7gZZdI8vY13J36-Zwucd5KLLjNNVlGtIrzZIBKk7px5PfCRWRQUgYZ0t-2ZL1s61-dxGpt4lF-xKYSFzl1-3RYZBHIdYTokIAb_I4CiiSOh5uG4DPkWWlJrE6i77p6A5dn336cntM-3wK1sixbWnjJrQo6D04z9GOdCrXkRuRW6toVjHlZC6d4YDhWlS8Mbq2DEsFoYVATlr-F7WbR-PdAygn6PaYMwZVB8DqooLzShSvtZILmYTMohv6vbE9GHnNizKsUFOeq6nRWoc6qpLNKZXA81ll2VBxPSh8Oaq36YbmqGG53Oc_RBcvg81iMAyr2Td34xbqT0UJwLjN411nB-LkUDSk5vrzcsI9RIJJ1b5Y0Nz8TaXek6eeCZXAyWNJDs_7_Fx-eJ_4RXrFo5ZGLUh3Cdvtn7Y_QaWrNp36U3AMgHhW-
  priority: 102
  providerName: Springer Nature
Title Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines
URI https://link.springer.com/article/10.1038/s41598-019-42456-8
https://www.ncbi.nlm.nih.gov/pubmed/31000738
https://www.proquest.com/docview/2211330976
https://www.proquest.com/docview/2211944335
https://pubmed.ncbi.nlm.nih.gov/PMC6472342
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFD7sBWVfxLtd1yGCb1qd5jJJHkTGYZdlwEXUgXkrTZPsLtZ2dqYD7v_wB5tLO7ru6oNQKDQJbXO-cE6Sk-8DeCEU1tIQnSqJWUqtm6AonbFUO2fjAEXKYRkSZE9GxzM6nbP5FvRyR10Hrm6c2nk9qdmyev394vKdG_Bv45Fx8WblnJA_KJbJNOzjpWIbdp1n4l7R4EMX7keubyxpJruzMzc33YPbYc07nFj53VVdiz-vp1H-sZcaXNTRXbjTxZZoHMFwD7ZMfR9uRbXJywfwY2KqKnV_ZwJVbn2KFj6lRRvU51OjotboW6N9-lCwGOo1clu0XrTF11hjtVZ-vd8nsCLtiXc7zSzUWHTq83iQrZpl5IlCgQjivEbu6sVYWuSbIx_grh7C7Ojwy-Q47UQZ0pJx3qaZYaQUVg6tltgFu1rYghFFhyWThc4wNqygWhCL3YAWJlNu_m0FtUpSxSkrySPYqZvaPAHERy44UtxazS0lhRVWGCEzzcvRyGGoTCDr-z8vO8ZyL5xR5WHnnIg8mi935suD-XKRwMtNm0Xk6_hn7YPerHkPvRy7OTEhQxenJfB8U-xGne-bojbNOtaRlBLCEngcUbB5XQ-fBPgVfGwqeEbvqyX1-Vlg9vZc_oTiBF71SPr1WX__i_3_ftFT2MMe-567UhzATrtcm2cuyGrVALb5nA9gdzyefp66-_vDk4-f3NPJaDIICxeDMLZ-Aoa0LNo
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwELVKEaIXxDeBAkaCE1hNbGftHBBChWpLS0-ttLcQx3ap2CahmxXq_-B38BuZcT6qpaK3SnuLk2wyz56ZzPg9Ql5rw23mhGUm4ymTHhIUY5OUWXA2AChRxmVokD2YTI_kl1k6WyN_hr0w2FY5rIlhobZ1id_ItzhkKpB7g_f80PxkqBqF1dVBQqODxZ47_wUp2-L97iew7xvOdz4fbk9ZryrAylSpliUuFaX2WextxiFas9oXqTAyLtOssAnnLi2k1cJzQKR2iYEE0mvpTSaNkmkp4Lo3yE1wvDEme2qmxm86WDWTSdbvzYmF3lqAf8Q9bEnGQomR6VX_dymovdyb-U-BNvi9nbvkTh-w0o8dwu6RNVfdJ7c6CcvzB-T3tpvPWQMrZuDfrY5pg30y1tGhSZsWlaWntcWepAADOgjvtnTZtMWPbsRiabCIgF2x1CKbby_ERWtPj7E5iPp5fdaRT9HALnFSUfgNCi8txdMpRs2Lh-ToWmzyiKxXdeWeEKomEHEZ5b1VXorCa6-dzhKryskEgFlGJBnef172NOioxjHPQzle6LyzWQ42y4PNch2Rt-M5TUcCcuXozcGseb8gLPIL-Ebk1XgYpjK-m6Jy9bIbk0kpRBqRxx0KxtuFOowScHG1go9xANKErx6pTr4HunAUCBCSR-TdgKSLv_X_p3h69VO8JLenh1_38_3dg71nZIMjwpEBU2-S9fZs6Z5DqNaaF2F-UPLtuifkXyP4U4w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VrUBcEN8EChgJThDtxnY2zgEhaLtqKVpViEq9hSS2S9VtEpqsUP8Hv4Zfx4zzUS0VvVXaW5xkk3n2zGSe5wG8VhnXsRHaz2Ie-tJigpLpIPQ1OhsElMgnuSPIzqc7B_LzYXi4Bn_6vTBEq-zXRLdQ6zKnb-RjjpkK5t7oPce2o0Xsb80-VD99UpCiSmsvp9FCZM-c_8L0rX6_u4W2fsP5bPvb5o7fKQz4eRhFjR-YUOTKxhOrY46Rm1Y2DUUmJ3kYpzrg3ISp1EpYjuhUJsgwmbRK2iyWWSTDXOB1b8B6RFnRCNY_bc_3vw5feKiGJoO426kzEWpco7ekHW1B7LuCo69WveGlEPcyU_Ofcq3zgrO7cKcLX9nHFm_3YM0U9-FmK2h5_gB-b5rFwq9w_XTdeIsjVhFrRhvWU7ZZWmh2WmpiKDlQsF6Gt2HLqklP2hH1MqOSAnFkmabevp0sFystOyKqELOL8qxtRcVcr4njguGv13tpGJ3OKIauH8LBtVjlEYyKsjBPgEVTjL-yyFodWSlSq6wyKg50lE-nCNPcg6B__0neNUUnbY5F4orzQiWtzRK0WeJsligP3g7nVG1LkCtHb_RmTbrloU4uwOzBq-EwTmx6N2lhymU7JpZSiNCDxy0Khtu5qkwk8OLRCj6GAdQ0fPVIcfzDNQ8nuQAhuQfveiRd_K3_P8XTq5_iJdzCyZh82Z3vPYPbnABO7TDVBoyas6V5jnFbk73oJgiD79c9J_8CkMtZJw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell-penetrating+peptide+sequence+and+modification+dependent+uptake+and+subcellular+distribution+of+green+florescent+protein+in+different+cell+lines&rft.jtitle=Scientific+reports&rft.au=Patel%2C+Sanjay+G.&rft.au=Sayers%2C+Edward+J.&rft.au=He%2C+Lin&rft.au=Narayan%2C+Rohan&rft.date=2019-04-18&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=9&rft_id=info:doi/10.1038%2Fs41598-019-42456-8&rft_id=info%3Apmid%2F31000738&rft.externalDocID=PMC6472342
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon